StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3024% below fair value
$14.82−0.27 (-1.79%)

Close on Nov 20, 2026Market cap $1.92BP/E –Yield –

NeoGenomics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

NeoGenomics's free cash flow for the twelve months ending Sep 30, 2026 was -$28.58M. For fiscal 2025 it was -$21.78M. The highest annual figure on record is $30.48M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.78M–
FY2024Dec 31, 2024-$34.04M–
FY2023Dec 31, 2023-$30.71M–
FY2022Dec 31, 2022-$96.88M–
FY2021Dec 31, 2021-$90.87M–
FY2020Dec 31, 2020-$27.64M-927.4%
FY2019Dec 31, 2019$3.34M-89.0%
FY2018Dec 31, 2018$30.48M+601.1%
FY2017Dec 31, 2017$4.35M-68.8%
FY2016Dec 31, 2016$13.94M+233.7%
FY2015Dec 31, 2015$4.18M-26.4%
FY2014Dec 31, 2014$5.68M+2528.7%
FY2013Dec 31, 2013$216.00K–
FY2012Dec 31, 2012-$3.11M–
FY2011Dec 31, 2011-$828.00K–
FY2010Dec 31, 2010-$2.97M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$20.66M-3724.2%
Q2 FY2026Jun 30, 2026$11.74M-16.2%
Q1 FY2026Mar 31, 2026-$13.14M–
Q4 FY2025Dec 31, 2025-$6.53M–
Q3 FY2025Sep 30, 2025$570.00K–
Q2 FY2025Jun 30, 2025$14.01M+1620.8%
Q1 FY2025Mar 31, 2025-$29.83M–
Q4 FY2024Dec 31, 2024-$1.80M-116.8%
Q3 FY2024Sep 30, 2024-$1.55M–
Q2 FY2024Jun 30, 2024$814.00K–
Q1 FY2024Mar 31, 2024-$31.50M–
Q4 FY2023Dec 31, 2023$10.73M–
Q3 FY2023Sep 30, 2023-$9.77M–
Q2 FY2023Jun 30, 2023-$9.04M–
Q1 FY2023Mar 31, 2023-$22.62M–
Q4 FY2022Dec 31, 2022-$8.22M–
Q3 FY2022Sep 30, 2022-$24.12M–
Q2 FY2022Jun 30, 2022-$27.29M–
Q1 FY2022Mar 31, 2022-$37.26M–
Q4 FY2021Dec 31, 2021-$31.76M–
Q3 FY2021Sep 30, 2021-$22.74M–
Q2 FY2021Jun 30, 2021-$22.74M–
Q1 FY2021Mar 31, 2021-$13.62M–
Q4 FY2020Dec 31, 2020-$5.52M–
Q3 FY2020Sep 30, 2020-$7.33M-164.8%
Q2 FY2020Jun 30, 2020-$3.14M–
Q1 FY2020Mar 31, 2020-$11.64M-501.3%
Q4 FY2019Dec 31, 2019-$2.72M-122.2%
Q3 FY2019Sep 30, 2019$11.32M+81.6%
Q2 FY2019Jun 30, 2019-$8.16M-445.4%
Q1 FY2019Mar 31, 2019$2.90M-69.9%
Q4 FY2018Dec 31, 2018$12.23M+447.1%
Q3 FY2018Sep 30, 2018$6.23M+21.4%
Q2 FY2018Jun 30, 2018$2.36M+41.4%
Q1 FY2018Mar 31, 2018$9.65M–
Q4 FY2017Dec 31, 2017$2.24M–
Q3 FY2017Sep 30, 2017$5.13M–
Q2 FY2017Jun 30, 2017$1.67M–
Q1 FY2017Mar 31, 2017-$4.69M–
Q4 FY2016Dec 31, 2016-$2.45M–

More NeoGenomics figures

See a number that looks wrong?